Regal Rexnord Corporation
Regal Rexnord Corporation (RRX) Financial Performance & Income Statement Overview
Explore the financials of Regal Rexnord Corporation (RRX), including yearly and quarterly data on income, cash flow, and balance sheets.
Regal Rexnord Corporation (RRX) Income Statement & Financial Overview
Analyze Regal Rexnord Corporation’s RRX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.42B | $1.46B | $1.48B | $1.55B |
| Cost of Revenue | $890.50M | $950.50M | $921.10M | $978.40M |
| Gross Profit | $527.60M | $510.60M | $556.30M | $569.20M |
| Gross Profit Ratio | $0.37 | $0.35 | $0.38 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $388.20M |
| Operating Expenses | $367.90M | $358.70M | $382.20M | $388.20M |
| Total Costs & Expenses | $1.26B | $1.33B | $1.30B | $1.37B |
| Interest Income | $4.20M | $5.60M | $5.10M | $5.00M |
| Interest Expense | $90.20M | $94.60M | $98.00M | $101.70M |
| Depreciation & Amortization | $125.50M | -$4.90M | $127.40M | $127.00M |
| EBITDA | $288.70M | $262.20M | $308.20M | $327.00M |
| EBITDA Ratio | $0.20 | $0.18 | $0.21 | $0.21 |
| Operating Income | $159.70M | $128.10M | $174.10M | $181.00M |
| Operating Income Ratio | $0.11 | $0.09 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | -$86.70M | -$90.30M | -$92.70M | -$97.00M |
| Income Before Tax | $73.00M | $38.40M | $81.40M | $96.90M |
| Income Before Tax Ratio | $0.05 | $0.03 | $0.06 | $0.06 |
| Income Tax Expense | $15.50M | -$3.60M | $8.40M | $33.90M |
| Net Income | $57.30M | $41.20M | $72.70M | $62.50M |
| Net Income Ratio | $0.04 | $0.03 | $0.05 | $0.04 |
| EPS | $0.86 | $0.62 | $1.09 | $0.94 |
| Diluted EPS | $0.86 | $0.62 | $1.09 | $0.94 |
| Weighted Avg Shares Outstanding | $66.30M | $66.20M | $66.40M | $66.50M |
| Weighted Avg Shares Outstanding (Diluted) | $66.50M | $66.60M | $66.70M | $66.50M |
Over the past four quarters, Regal Rexnord Corporation demonstrated steady revenue growth, increasing from $1.55B in Q2 2024 to $1.42B in Q1 2025. Operating income reached $159.70M in Q1 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $288.70M, reflecting operational efficiency. Net income rose to $57.30M, with EPS at $0.86. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan